SG Americas Securities
LRMR icon

SG Americas Securities’s Larimar Therapeutics LRMR Stock Holding History

SG Americas Securities’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,757
Closed -$60K – 3489
2025
Q4 		$60K Buy
+15,757
New +$61.3K ﹤0.01% 3333
2025
Q2 		– Sell
-14,974
Closed -$32K – 3308
2025
Q1 		$32K Sell
14,974
-4,417
-23% -$14K ﹤0.01% 3326
2024
Q4 		$75K Buy
19,391
+5,042
+35% +$33.3K ﹤0.01% 2815
2024
Q3 		$94K Buy
+14,349
New +$115K ﹤0.01% 3096
2024
Q1 		– Sell
-14,159
Closed -$64K – 3228
2023
Q4 		$64K Buy
14,159
+3,039
+27% +$10.3K ﹤0.01% 2882
2023
Q3 		$44K Buy
+11,120
New +$42.1K ﹤0.01% 2965
2020
Q1 		– Sell
-1,792
Closed -$24K – 3586
2019
Q4 		$24K Sell
1,792
-61
-3% -$583 ﹤0.01% 3136
2019
Q3 		$16K Sell
1,853
-400
-18% -$4.39K ﹤0.01% 2909
2019
Q2 		$32K Buy
2,253
+954
+73% +$25.4K ﹤0.01% 2961
2019
Q1 		$43K Buy
+1,299
New +$66.6K ﹤0.01% 3220
2017
Q2 		– Sell
-935
Closed -$52K – 3371
2017
Q1 		$52K Sell
935
-20
-2% -$993 ﹤0.01% 3108
2016
Q4 		$36K Buy
+955
New +$38.7K ﹤0.01% 2953
2015
Q4 		– Sell
-594
Closed -$228K – 2863
2015
Q3 		$228K Buy
+594
New +$268K ﹤0.01% 1375
2015
Q1 		– Sell
-272
Closed -$101K – 2849
2014
Q4 		$101K Buy
+272
New +$70.1K ﹤0.01% 2920

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

SG Americas Securities's LRMR Position: Q1 2026 in Review

SG Americas Securities sold out of Larimar Therapeutics (LRMR) in Q1 2026, closing a stake of 15,757 shares — an estimated $60K sold.

SG Americas Securities first reported a position in LRMR in Q4 2014 and held it in 14 quarters. The position peaked at $228K in Q3 2015. 162 funds tracked by Wall St. Rank hold LRMR as of Q1 2026.

  • SG Americas Securities reported no remaining Larimar Therapeutics position as of Q1 2026 after selling out during the quarter.
  • SG Americas Securities sold 15,757 Larimar Therapeutics shares in Q1 2026, an estimated $60K.
  • SG Americas Securities first reported a position in Larimar Therapeutics in Q4 2014 and held it in 14 quarters.
  • SG Americas Securities's Larimar Therapeutics position peaked at $228K in Q3 2015.
  • 162 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.